JASPER, Ind., April 24, 2018 -- Kimball International, Inc. (NASDAQ:KBAL)
The Board of Directors of Kimball International, Inc. held a Board meeting during which they declared a quarterly dividend of seven cents ($0.07) per share for all outstanding shares of common stock payable July 13, 2018, to share owners of record on June 25, 2018.
About Kimball International, Inc.
Kimball International, Inc. creates design driven, innovative furnishings sold through our family of brands: Kimball, National, and Kimball Hospitality. Our diverse portfolio offers solutions for the workplace, learning, healing, and hospitality environments. Dedicated to our Guiding Principles, our values and integrity are evidenced by public recognition as a highly trusted company and an employer of choice. “We Build Success” by establishing long-term relationships with customers, employees, suppliers, share owners and the communities in which we operate. To learn more about Kimball International, Inc. (NASDAQ:KBAL), visit www.kimballinternational.com.
For additional information contact:
Dennis Gerber
Mail to: [email protected]


Google Expands Gemini Enterprise With AI Tools for Legal Sector
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
Luxshare Shares Rise as First-Half Profit Jumps 18%
Bathla Group Hires Administrators as Australia Housing Slump Deepens
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Trump Buys SpaceX Shares After Record IPO
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Mercer International Stock Surges 45% on C$20 Million Canada Funding
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
SK Hynix Shares Fall as Workers Reject Wage Deal
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 



